US · 1 entry · 1 publication
ProQR Therapeutics N.V.
No entry states a stance.
Free during launch: log in or sign up with your email to see it.
Sign up freeSubstack · Insider Buying Insights
CEO Daniel Anton de Boer doubled his stake with a 261,000 purchase as insider buying continues at ProQR Therapeutics.
Since publication −25.8% α −27.7 pp vs S&P 500 · USD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.